Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BNOS 2022 | Targeting mechanisms of resistance to radiotherapy in glioblastoma

Ross Carruthers, PhD, University of Glasgow, Glasgow, UK, gives an overview on how glioblastomas can become resistant to radiotherapy. Despite the exact pathways being poorly understood, it is generally understood that cancer stem cells and tumor heterogeneity are involved in resistance. Cancer stem cells tend to active DNA repair pathways more frequently and so targeting these stem cells will be beneficial to resensitize patients to radiotherapy. This interview took place at the British Neuro-Oncology Society (BNOS) Annual Meeting 2022.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.